Reproduction and Development Group Symposium on 'Nutrition and immunology from fetal life to old age': The influence of the maternal uterine immune response on placentation in human subjects

Proceedings of the Nutrition Society

Volumn 58, Issue 1, 1999, Pages 69-73

  King, Ashley ^a   Loke, Y W ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Immunology; Natural killer cells; Placenta; Trophoblast

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN;

ALLOIMMUNITY; ANTIGEN EXPRESSION; CELL SUBPOPULATION; CONFERENCE PAPER; FETUS GROWTH; HUMAN; IMMUNE RESPONSE; LEUKOCYTE; MOLECULAR DYNAMICS; MOTHER FETUS RELATIONSHIP; NATURAL KILLER CELL; NIDATION; T LYMPHOCYTE; TROPHOBLAST;

EMBRYONIC AND FETAL DEVELOPMENT; FEMALE; HLA ANTIGENS; HUMANS; KILLER CELLS, NATURAL; LEUKOCYTES; PLACENTATION; PREGNANCY; TROPHOBLASTS; UTERUS;

MAMMALIA;

EID: 0032938456     PISSN: 00296651     EISSN: None     Source Type: Journal    
DOI: 10.1079/pns19990010     Document Type: Conference Paper

References (36)

1. Barker DJB (1994) Mothers, Babies, and Disease in Later Life. London: BMJ Publishing Group.
2. Bensussan A, Mansur I-G & Mallet V (1995) Detection of membrane-bound HLA-G translated products with a specific monoclonal antibody. Proceedings of the National Academy of Sciences USA 92, 10292-10296.
3. Biassoni R, Cantoni C, Falco M, Verdiani S, Bottino C, Vitale M, Conte R, Poggi A, Moretta A & Moretta L (1996) The human leukocyte antigen (HLA)-C-specific 'activatory' or 'inhibitory' natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions. Journal of Experimental Medicine 183, 645-650.
4. Braud VM, Allan DSJ, O'Callaghan CA, Soderstrom K, D'Andrea A, Ogg GS, Lazetic S, Young NT, Bell JI, Phillips JH, Lanier LL & McMichael AJ (1998) HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 391, 795-799.
5. Chumbley G, King A, Gardner L, Howlett S, Holmes N & Loke YW (1994) Generation of an antibody to HLA-G in transgenic mice and demonstration of the tissue reactivity of this antibody. Journal of Reproductive Immunology 27, 173-186.
6. Colonna M, Borsellino G, Galco M, Ferrara GB & Strominger JL (1993) HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells. Proceedings of the National Academy of Sciences USA 90, 12000-12004.
7. Colonna M, Navarro F, Bellón T, Llano M, Garcia P, Samaridis J, Angman L, Cella M & López-Botet M (1997) A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. Journal of Experimental Medicine 186, 1809-1818.
8. Colonna M, Samaridis J, Cella M, Angman L, Allen RL, O'Callaghan CA, Dunbar R, Ogg GS, Cerundolo V & Rolink A (1998) Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules. Journal of Immunology 160, 3096-3100.
9. Cooper DW, Brennecke SP & Wilton AM (1993) Genetics of pre-eclampsia. Hypertension in Pregnancy 12, 1-23.
10. Diehl M, Münz C, Keilholz W, Stevanovic S, Holmes N, Loke YW & Rammensee HG (1996) Non-classical HLA-G molecules are classical peptide presenters. Current Biology 6, 305-314.
11. Ellis SA, Palmer MS & McMichael J (1990) Human trophoblast and the choriocarcinoma cell line BeWo express a truncated HLA class I molecule. Journal of Immunology 144, 731-735.
12. Gumperz JE & Parham P (1995) The enigma of the natural killer cell. Nature 378, 245-248.
13. Haig D (1993) Genetic conflicts in human pregnancy. Quarterly Review of Biology 68, 495-532.
14. Hiby SE, King A, Sharkey AM & Loke YW (1997) Human uterine NK cells have a similar repertoire of Killer Inhibitory and Activatory receptors to those found in blood, as demonstrated by RT-PCR and sequencing. Molecular Immunology 34, 419-430.
15. Janeway CA & Travers P (1996) Immunobiology: The Immune System in Health and Disease. London: Current Biology Ltd.
16. King A, Boocock C, Sharkey A, Gardner L, Beretta A, Siccardi AG & Loke YW (1996) Evidence for the expression of HLA-C class I mRNA and protein by human first trimester trophoblast. Journal of Immunology 156, 2068-2076.
17. Kovats S, Main EK, Librach C, Stubblebine M, Fisher SJ & DeMars R (1990) A class I antigen, HLA-G, expressed in human trophoblasts. Science 248, 220-223.
18. Lanier LL, Chang C, Spits H & Phillips JD (1992) Expression of cytoplasmic CD3e proteins activated human adult natural killer (NK) cells and CD3γ,δ,ε complexes in fetal NK cells. Journal of Immunology 149, 1876-1880.
19. Lanier LL & Phillips JH (1996) Inhibitory MHC class I receptors on NK cells and T cells. Immunology Today 17, 86-91.
20. Lazetic S, Chang C, Houchins JP, Lanier LL & Phillips JH (1996) Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits. Journal of Immunology 157, 4741-4745.
21. Le Bouteiller P & Lenfant F (1996) Antigen-presenting function(s) of the non-classical HLA-E, -F and -G class I molecules: the beginning of a story. Research in Immunology 147, 301-313.
22. Lee N, Malacko AR, Ishitani A, Chen MC, Bajorath J, Marquardt H & Geraghty DE (1995) The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association. Immunity 3, 591-600.
23. Loke YW & King A (1995) Human Implantation: Cell Biology and Immunology. Cambridge: Cambridge University Press.
24. McMaster MT, Librach CL, Zhou Y, Lim KH, Janatpour MJ, DeMars R, Kovats S, Damsky C & Fisher SJ (1995) Human placental HLA-G expression is restricted to differentiated cytotrophoblasts. Journal of Immunology 154, 3771-3778.
25. Medawar PB (1953) Some immunological and endocrinological problems raised by the evolution of viviparity in vertebrates. Proceedings of the Society for Experimental Biology, pp. 320-338. New York: Academic Press.
26. Moretta A & Moretta L (1997) HLA class I specific inhibitory receptors. Current Opinion in Immunology 9, 694-701.
27. Parham P (1995) Antigen presentation by class I major histocompatibility complex molecules: a context for thinking about HLA-G. American Journal of Reproductive Immunology 34, 10-19.
28. Phillips JH, Chang CW, Mattson J, Gumperz JE, Parham P & Lanier LL (1996) CD94 and a novel associated protein (94AP) form a NK cell receptor involved in the recognition of HLA-A, HLA-B, and HLA-C allotypes. Immunity 5, 163-172.
29. Pijnenborg R (1994) Trophoblast invasion. Reproductive Medicine Review 3, 53-73.
30. Terje R, Rasmussen S, Brunborg H, Gjessing HK, Lie-Nielsen E & Irgens LM (1998) Fetal and maternal contributions to risk of pre-eclampsia: population based study. British Medical Journal 316, 1343-1347.
31. van der Ven K & Ober C (1994) HLA-G polymorphisms in African Americans. Journal of Immunology 153, 5628-5633.
32. Verma S, King A & Loke YW (1997) Expression of killer-cell inhibitory receptors (KIR) on human uterine NK cells. European Journal of Immunology 27, 979-983.
33. Wallenburg HCS & Visser W (1994) Pregnancy-induced hypertensive disorders. Current Opinion in Obstetrics and Gynaecology 6, 19-29.
34. Yang Y, Chu W, Geraghty DE & Hunt JS (1996) Expression of HLA-G in human mononuclear phagocytes and selective induction by IFN-γ. Journal of Immunology 156, 4224-4231.
35. Yokoyama WM (1998) HLA class I specificity for natural killer cell receptor CD94NKG2A: two for one in more ways than one. Proceedings of the National Academy of Sciences USA 95, 4791-4794.
36. Zemmour J & Parham P (1992) Distinctive polymorphism at the HLA-C locus: implications for the expression of HLA-C. Journal of Experimental Medicine 176, 937-950.